Association Between Plasma Anti-Factor Xa Concentrations and Large Artery Occlusion in Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants for Non-valvular Atrial Fibrillation.
作者信息
Kim Dae-Hyun, Kwak Byung-Cheol, Yoon Byeol-A, Cha Jae-Kwan, Park Jong-Sung, Kwak Min-Sun, Woo Kwang-Sook, Han Jin-Yeong
机构信息
Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
Department of Neurology, Pohang Stroke and Spine Hospital, Pohang, Korea.
出版信息
Ann Lab Med. 2024 Sep 1;44(5):459-462. doi: 10.3343/alm.2024.0036. Epub 2024 Apr 18.
Abstract
摘要
相似文献
1
Association Between Plasma Anti-Factor Xa Concentrations and Large Artery Occlusion in Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants for Non-valvular Atrial Fibrillation.
Ann Lab Med. 2024 Sep 1;44(5):459-462. doi: 10.3343/alm.2024.0036. Epub 2024 Apr 18.
2
Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke/transient ischemic attack patients with non-valvular atrial fibrillation.
J Neurol Sci. 2019 Jul 15;402:162-166. doi: 10.1016/j.jns.2019.05.023. Epub 2019 May 23.
3
Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation.
J Neurol. 2020 Jul;267(7):2007-2012. doi: 10.1007/s00415-020-09795-3. Epub 2020 Mar 23.
4
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
J Am Heart Assoc. 2020 Dec 15;9(24):e018984. doi: 10.1161/JAHA.120.018984. Epub 2020 Dec 9.
5
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
J Am Heart Assoc. 2018 Sep 4;7(17):e009507. doi: 10.1161/JAHA.118.009507.
6
Efficacy of direct factor Xa inhibitors compared to warfarin in preventing stroke in adults with non-valvular atrial fibrillation: a systematic review protocol.
JBI Database System Rev Implement Rep. 2016 Jun;14(6):69-77. doi: 10.11124/JBISRIR-2016-002613.
7
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.
Adv Ther. 2017 Jun;34(6):1283-1290. doi: 10.1007/s12325-017-0550-7. Epub 2017 May 10.
8
Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation.
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):656-664. doi: 10.1177/10742484211049919. Epub 2021 Sep 24.
9
Insights Into Direct Oral Anticoagulant Therapy Implementation of Stroke Survivors with Atrial Fibrillation in an Ambulatory Setting.
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105530. doi: 10.1016/j.jstrokecerebrovasdis.2020.105530. Epub 2020 Dec 14.
10
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.
Tohoku J Exp Med. 2016 Dec;240(4):259-268. doi: 10.1620/tjem.240.259.
本文引用的文献
1
Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity.
J Stroke. 2022 Jan;24(1):88-97. doi: 10.5853/jos.2020.04952. Epub 2022 Jan 31.
2
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
3
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
Stroke. 2019 Apr;50(4):873-879. doi: 10.1161/STROKEAHA.118.023877.
6
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
Eur Heart J. 2019 May 14;40(19):1518-1527. doi: 10.1093/eurheartj/ehy807.
7
Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry.
Int J Stroke. 2014 Jun;9(4):514-8. doi: 10.1111/ijs.12199. Epub 2013 Nov 21.
8
Association of atrial fibrillation with mortality and disability after ischemic stroke.
Neurology. 2013 Aug 27;81(9):825-32. doi: 10.1212/WNL.0b013e3182a2cc15. Epub 2013 Jul 31.
Zotero 插件